Science and technology company Leidos announced it has been awarded a new prime contract by the Centers for Disease Control and Prevention to provide bioinformatics and scientific computing support services.
The firm-fixed-price contract was awarded by CDC’s Office of Acquisition Services and holds a maximum value of over $13 million for a period of performance of approximately 5 years if all options are exercised.
Leidos is thrilled to expand its work with CDC into bioinformatics and high-performance scientific computing, said Liz Porter, Leidos Health Group president.
“Our world-class scientific and technical team will help CDC investigate infectious pathogens and generate new discoveries to help prevent future pandemics,” she added. “These discoveries could lead to transformative advances in public health and Leidos is proud to assist them in this pursuit.”
Through this contract, Leidos will assist CDC’s Office of Advanced Molecular Detection to expand the agency’s capacity for scientific computing and bioinformatics. This includes supporting CDC personnel through IT and high-performance analytical activities, including genomics, proteomics, high-performance computing and managing extremely large datasets.